| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Onkure Therapeutics, Inc. (OKUR) has 13 insiders with recent SEC Form 4 filings, including 14 buys and 1 sell. OKUR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.71M | $5.82M | - | |
| CEO | 330.0K | $1.12M | - | |
| CFO | 110.0K | $374.6K | - | |
| Other | 110.0K | $374.6K | - | |
| Other | 110.0K | $374.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | O'Donnell Niall | Director | Buy | 125,000 | $8.00 | $1,000,000.00 | +6.1% | -28.4% | -81.4% | |
| Sep 1, 2022 | Cruse Michael59 | Chief Operating Officer | Buy | 7,500 | $3.39 | $25,447.50 | +121.0% | -36.3% | +80.6% | |
| Aug 31, 2022 | Cruse Michael59 | Chief Operating Officer | Buy | 7,255 | $3.20 | $23,243.39 | +11.1% | -30.5% | +91.1% | |
| Aug 25, 2021 | Jindal Vineet R. | Chief Financial Officer | Buy | 5,000 | $7.44 | $37,176.50 | New | +13.2% | -52.4% | |
| Aug 25, 2021 | Flesher Gregory J. | President And CEO | Buy | 8,000 | $8.00 | $64,000.00 | New | +13.2% | -52.4% | |
| Aug 25, 2021 | Cruse Michael59 | Senior Vp-corporate Operations | Buy | 2,500 | $7.45 | $18,616.00 | New | +13.2% | -52.4% | |
| Jul 14, 2021 | Johnson Wendy S. | Chief Development Officer | Sell | 111,736 | $8.50 | $949,756.00 | -100% | -22.3% | -65.2% | |
| Jul 14, 2021 | Muralidhar Bali | Director | Buy | 111,736 | $8.50 | $949,756.00 | +5.7% | -22.3% | -65.2% | |
| Jun 23, 2021 | Muralidhar Bali | Director | Buy | 20,710 | $9.28 | $192,244.72 | +1.1% | -18.7% | -75.9% | |
| Jun 22, 2021 | Muralidhar Bali | Director | Buy | 47,274 | $8.94 | $422,413.74 | +1.2% | -11.4% | -74.8% |